SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-067723
Filing Date
2023-03-10
Accepted
2023-03-10 17:07:24
Documents
9
Effectiveness Date
2023-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 d414522ds8.htm S-8 61087
2 EX-5.1 d414522dex51.htm EX-5.1 7810
3 EX-23.2 d414522dex232.htm EX-23.2 2492
4 EX-99.4 d414522dex994.htm EX-99.4 28696
5 EX-FILING FEES d414522dexfilingfees.htm EX-FILING FEES 37990
6 GRAPHIC g414522g0309080603003.jpg GRAPHIC 3245
7 GRAPHIC g414522g0309080603165.jpg GRAPHIC 5237
8 GRAPHIC g414522snap1.jpg GRAPHIC 5320
9 GRAPHIC g414522snap2.jpg GRAPHIC 4117
  Complete submission text file 0001193125-23-067723.txt   164716
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270475 | Film No.: 23724623
SIC: 8071 Services-Medical Laboratories